GENTA INCORPORATED /DE/
4, 1997-07-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENTA INCORPORATED /DE/, 4, 1997-07-10
Next: GENTA INCORPORATED /DE/, 4, 1997-07-10



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Aries Domestic Fund, LP
   787 Seventh Avenue
   44th Floor
   New York, NY  10019
2. Issuer Name and Ticker or Trading Symbol
   Genta Incorporated
   GNTAC
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   06/30/97
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Line of Credit        |$2.50   |06/6/|J(2)| |17,500     |   |06/06|06/06|Common  |17,500     |(2)    |17,500      |D  |            |
Warrants              |        |97   |    | |           |   |/97  |/02  |        |           |       |            |   |            |
                      |        |     |    | |           |   |     |     |        |           |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Series D Convertible P|$0.94   |06/30|P   | |3,500      |   |N/A  |N/A  |Common  |372,340    |$304,50|24,500 (1)  |D  |            |
referred              |        |/97  |    | |           |   |     |     |        |           |0(3)   |            |   |            |
                      |        |     |    | |           |   |     |     |        |           |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class D Warrants      |$0.94   |06/30|P(3)| |17,500     |   |07/01|06/30|Common  |(3)        |(3)    |17,500      |D  |            |
                      |        |/97  |    | |           |   |97   |/02  |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1) Includes Series D Convertible Preferred Stock acquired both by conversion of
12% Senior Secured Convertible Bridge Notes (the "Bridge Notes") and by purchase
in  a  private  placement.  Does  not,  however,  include  shares  of  Series  D
Convertible  Preferred  Stock  issuable  upon  conversion of the interest on the
Bridge Notes.
(2) Received in  consideration  of extension of a $175,000 line of credit to the
Issuer.
(3) The Series D Preferred Stock and Class D Warrants  purchased on 6/30/97 were
included  in  Units  for  which  the  Reporting  Person  paid  an  aggregate  of
$304,500.

SIGNATURE OF REPORTING PERSON
/s/ Lindsay A. Rosenwald, M.D., President
Paramount Capital Asset Management, Inc., General Partner
The Aries Domestic Fund, L.P.
DATE
7/10/97

<PAGE>
                                  Attachment A


        Reporting Person:           The Aries Domestic Fund, L.P.
        Issuer:                     Genta Incorporated (GNTAC)
        Statement For:              June/1997

         Paramount Capital Asset  Management,  Inc.  ("Paramount"),  the General
Partner of the Aries Domestic Fund, L.P. (the "Partnership"), also serves as the
Investment  Manager to The Aries Trust (the  "Trust"),  a Cayman  Islands trust,
which also owns  securities of the Issuer.  Lindsay A.  Rosenwald,  M.D., is the
sole shareholder of Paramount.  Paramount and Dr. Rosenwald disclaim  beneficial
ownership of the securities held by the Partnership and the Trust, except to the
extent of their pecuniary interest therein.



                                   Page 3 of 3



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission